CompletedPhase 2NCT00674440
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Philadelphia
- Principal Investigator
- Lisa J States, MDChildren's Hospital of Philadelphia
- Intervention
- F-DOPA(drug)
- Enrollment
- 106 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2009
Study locations (1)
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Collaborators
University of Pennsylvania
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00674440 on ClinicalTrials.gov